...
首页> 外文期刊>Journal of the International Aids Society >When doctors come to prison – a pilot project for better HIV care in correctional facilities
【24h】

When doctors come to prison – a pilot project for better HIV care in correctional facilities

机译:当医生入狱时–一项在监狱中改善艾滋病毒护理的试点项目

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Recent rearrangements in national policies regarding follow‐up of HIV‐infected inmates have determined that hospitals closest to the prison facility be responsible for their care. Our HIV Unit and the two prison facilities in the area have established a clinical protocol whereby a clinical team goes to the prisons for blood collecting and visits instead of having the inmates transported to the hospital. The purpose of the protocol, from a clinical point of view, was to: (i) promote adherence to blood tests and clinical visits; (ii) promote adherence to antiretroviral (ARV) therapy; (iii) facilitate ARV administration by promoting once‐daily‐dosing. This retrospective review looks back at the first year of protocol implementation between the HIV Unit of HPP Cascais Hospital and the prisons of Tires and Linhó. The purpose of this study is to characterize the demographics of our inmate population; assess the number of inmates on ARV and describe the regimens as PI‐ or NNRTI‐based and as once‐ or twice‐daily dosed; evaluate ARV efficacy by HIV viral load undetectability; and assess opportunity for ARV switch from twice‐ to once‐daily dosing. From April 2011 until June 2012 a total of 53 inmates were included in this protocol. The majority of patients were female (55%) as one of the prisons is mainly for female inmates. The median age is 36 years (from 23–59). The average time of follow‐up was 11 months (15 months maximum). From the total of 53 patients under study, 40 are currently under care, the other 13 having been released or transferred to other prison facilities. The majority of these patients are on ARV therapy (83%). By the end of follow‐up time 88% of patients were on a once‐daily dosed regimen; these are PI‐based in 69% and NNRTI‐based in 31%. At their last evaluation, 32/33 patients on therapy had undetectable HIV viremia (97%). As a conclusion, we assess that this protocol implementation has benefitted all parts: patients assure regular laboratory and clinical follow‐up, and avoid constraintful displacements to the hospital; prisons guarantee regular specialized medical assistance to inmates and save on multiple trips to the hospital; finally, the clinical team is rewarded with 100% adherence to visits and therapy, which is evident by 97% viral load undetectability. The major constraint found in this protocol was the difficulty in providing adequate discharge planning and linkage to care in the community due to frequent unannounced release of inmates.
机译:关于艾滋病毒感染囚犯的跟进的国家政策最近的重新安排已确定,距离监狱设施最近的医院应负责照料。我们的HIV部门和该地区的两个监狱设施已经建立了一项临床协议,由临床团队前往监狱进行采血和探视,而不是将囚犯运送到医院。从临床角度来看,该协议的目的是:(i)促进对血液检查和临床就诊的依从性; (ii)促进对抗逆转录病毒(ARV)治疗的依从性; (iii)通过促进每天一次给药来促进抗逆转录病毒药物的管理。这项回顾性回顾回顾了HPP卡斯凯什医院(HPP Cascais Hospital)HIV部门与提尔斯(Tires)和林霍(Linhó)监狱之间实施协议的第一年。这项研究的目的是描述我们囚犯人口的特征。评估抗逆转录病毒药物的囚犯人数,并将治疗方案描述为基于PI或NNRTI的方案以及每天一次或两次的剂量;通过无法检测到HIV病毒载量来评估ARV疗效;并评估将ARV从两次剂量转换为每天一次的机会。从2011年4月到2012年6月,该协议共包括53名囚犯。大部分患者是女性(55%),因为其中一所监狱主要是针对女囚犯的。中位年龄是36岁(从23岁到59岁)。平均随访时间为11个月(最多15个月)。在接受研究的53位患者中,目前有40位正在接受护理,其他13位已被释放或转移到其他监狱设施。这些患者大多数接受抗逆转录病毒疗法(83%)。到随访时间结束时,有88%的患者接受了每日一次的给药方案。其中基于PI的占69%,基于NNRTI的占31%。在他们的最后评估中,接受治疗的32/33名患者有无法检测到的HIV病毒血症(97%)。总而言之,我们评估了该协议的实施已使所有方面受益:患者确保定期进行实验室和临床随访,并避免到医院的转移;监狱保证定期为囚犯提供专业医疗帮助,并节省多次去医院的旅行;最终,临床团队获得100%的就诊和治疗依从性,这在97%的病毒载量不可检测性中得到了证明。该协议中发现的主要限制因素是,由于频繁的暗中释放囚犯而难以提供适当的出院计划并与社区的护理联系起来。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号